Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 661-670 of 711 for cancer

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. A Study to Evaluate the Incidence and Psychological Impact of Vaginal Cuff Dehiscence After Different Types of Hysterectomy

    Rochester, MN

  2. Effect of Agent Orange Exposure on Endocrine Tumor Aggressiveness

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  3. Human Blood and Tissues Repository for Neuroscience Research

    Jacksonville, FL

  4. A Study to Evaluate Thymoma Recurrence

    Rochester, MN

  5. A Study to Explore if it is Possible to Successfully Obtain Optical Coherence Tomography (OCT) Imaging and Data While Patients Undergo Brain Surgery

    Jacksonville, FL

  6. A Study of the Possible Use of a New Imaging Method with Glioma Tumors

    Rochester, MN, Scottsdale/Phoenix, AZ

  7. Exploring the Role of B-cell Activating Factor Receptor (BAFFR)-based Chimeric Antigen Receptor T-cell (CAR T) in BAFFR-expressing B-cell Hematologic Malignancies and Autoimmune Rheumatologic Disorders

    Jacksonville, FL

  8. Circulating Tumor Nucleic Acids to Monitor Treatment Response in Metastatic Melanoma Patients

    Scottsdale/Phoenix, AZ

  9. Quantitative Assessment of Tumor Ablation

    Rochester, MN

  10. A Study of Hematopoiesis in Patients with Monoclonal B Cell Lymphocytosis (MBL), B-Chronic Lymphocytic Leukemia (CLL), and Healthy Controls

    Rochester, MN

.

Mayo Clinic Footer